z-logo
Premium
Small‐Molecule Inhibitors of METTL3, the Major Human Epitranscriptomic Writer
Author(s) -
Bedi Rajiv K.,
Huang Danzhi,
Eberle Stefanie A.,
Wiedmer Lars,
Śledź Pawel,
Caflisch Amedeo
Publication year - 2020
Publication title -
chemmedchem
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.817
H-Index - 100
eISSN - 1860-7187
pISSN - 1860-7179
DOI - 10.1002/cmdc.202000011
Subject(s) - moiety , docking (animal) , stereochemistry , in silico , small molecule , ligand efficiency , chemistry , ligand (biochemistry) , cofactor , adenosine , molecule , biochemistry , enzyme , receptor , gene , medicine , nursing , organic chemistry
The RNA methylase METTL3 catalyzes the transfer of a methyl group from the cofactor S‐adenosyl‐L‐methionine (SAM) to the N 6 atom of adenine. We have screened a library of 4000 analogues and derivatives of the adenosine moiety of SAM by high‐throughput docking into METTL3. Two series of adenine derivatives were identified in silico , and the binding mode of six of the predicted inhibitors was validated by protein crystallography. Two compounds, one for each series, show good ligand efficiency. We propose a route for their further development into potent and selective inhibitors of METTL3.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom